Charles Trafton
May 27, 2016
Charles Trafton @ FlowPoint Capital Partners

Time For Houghton Mifflin to Divest Hitler’s Blood Money - Again

Adolf Hitler’s autobiographical manifesto Mein Kampf details a twisted world view, including a blueprint for his “Final Solution”, the methodical slaughter of six million Jews.

 

Boston-based publisher Houghton Mifflin Harcourt purchased the U.S. rights to Mein Kampf in 1979 for $37,254, an investment that appeared to pay off until a US News & World Report article sixteen years ago disclosed the ghoulish profit source. Since being “outed”, Houghton has donated its profits from the disgraceful tome to Jewish and Holocaust-related charities including the Anti-Defamation League, Facing History and Ourselves, and the Gerda and Kurt Klein Foundation.

 

However, in a recent shift in company policy, Houghton management has attempted to re-direct its blood money to charities with no connection to the Holocaust, such as Boston’s Museum of Fine Arts and the Boston Children’s Museum. Houghton CEO Linda Zecher explained her desire to “expand the reach of these funds to organizations that help shape the wider cultural and societal dialogue” in a Boston Globe op-ed. With blinding clarity, the Children’s Museum refused Houghton’s donation of Mein Kampf profits. The MFA has yet to act.

 

Houghton’s attempt to re-allocate its Hitler blood money obfuscates history and belittles the Holocaust. From a moral perspective, responsible companies shun profiteering from the sales of hate-related goods, but if Houghton feels compelled to publish this reprehensible text, it is only right that its profits fund Holocaust-related charities. Using these funds to curry favor in some other way is detestable, and the controversy couldn’t be more poorly-timed. Mein Kampf has quietly climbed best-seller lists, from Turkey in recent years to 2016 Germany, where in January an annotated edition was published legally for the first time since 1945, and sold out within hours on Amazon’s German site. Academic study of Mein Kampf is certainly legitimate, although historical studies alone cannot account for the increasing sales the genocidal tome is generating. Nationalist and far-right politics are on the rise in Europe, and according to the FBI, 62% of all anti-religious hate crimes in the United States are anti-Semitic.

 

We call on Houghton management to reverse course, and donate its Mein Kampf profits to Holocaust-related charities, should they locate willing recipients. Failing this, Houghton should disgorge itself of the publishing rights rather than retain earnings so tainted. We call on all Houghton stakeholders - students and readers of all stripes, school teachers, employees, Board members, shareholders, vendors, and customers to also support this recommendation.

 

Charles Trafton

Mr. Trafton is managing partner of FlowPoint Capital Partners, a Boston-based investment manager with a short position in Houghton Mifflin common stock.

MAY
6
, 2016
Time For Houghton Mifflin to Divest
H
itler’s Blood Money
-
Again
Adolf Hitler
s
autobiographical manifesto
Mein Kampf
details
a
twisted
world view, including
a blueprint
for
his
Final Solution
,
the methodical slaughter of
six
million Jews.
Boston
-
based
publisher
Houghton Mifflin
Harcourt
purchased the U
.
S
.
rights to
Mein Kampf
in 1979 for
$37,254
,
an investment that
appeared to pay
off until
a
US News & World Report
article
sixteen years
ago
disclosed
the
ghoulish
profit
source
.
Since being
outed
, Houghton
has
donate
d
its
profits from
the
disgraceful
tome
to
Jewish and Holocaust
-
related charities
inclu
ding the Anti
-
Defamation League,
Facing
History and Ourselves
,
and the
Gerda and Kurt Klein Foundation
.
However, in a recent shift in company policy, Houghton management has attempted to re
-
direct its
blood money
to charities with no connection to the Holocaust, such as Boston
s
Museum of Fine
Arts
and the Boston Children
s Museum.
Houghton CEO Linda Zecher explained
her
desire
to
expand the
reach of these funds to organizations that help shape the wider
cultural and societal dialogue
in a
Boston Globe op
-
ed
.
With blinding clarity, the
Children
s Museum refused Houghton
s donation of
Mein
Kampf
profits. T
he MFA has yet to act.
Houghton
s attempt to re
-
allocate its Hitler blood money obfuscates history
and
belittles
the Hol
ocaust
.
From a moral perspective, r
esponsible companies
shun
profiteer
ing
from the sales of hate
-
related
goods, but if Houghton feels compelled to publish this reprehensible text, it is only right that its p
rofits
fund
Holocaust
-
related charities.
Using these funds to curry favor
in
some
other way
is
detestable
, and
the
controversy
couldn
t be more poorly
-
timed.
Mein Kampf
has quietly climbed best
-
seller lists
,
from
Turkey
in recent years
to
2016
Germany, where
in January
a
n annotated edition was published
legally
for the first time since 1
945, and
sold out within
hours
on Amazon
s German site
.
A
cademic study of
Mein Kampf
is certainly legitimate, although
historical
studies
alone
cannot account for the increasing
sales the genocidal tome is generating.
Nationalist and far
-
right politics are on the rise in Euro
pe, a
nd
according to the FBI,
62
% of all
anti
-
religious
hate crimes
in the United States
are anti
-
Semitic.
We call on Houghton management to reverse course, and donate
its
Mein Kampf
profits
to Holocaust
-
re
lated charities, s
hould
they locate willing recipients.
Failing this, Houghton should disgorge itself of the
publishing rights
rather than retain earnings
so tainted
. We cal
l on all Houghton stakeholders
-
students
and readers of all stripes, school teachers,
employees, Board mem
bers,
shareholders,
vendors
, and
customers
to
also support
this recommendation.
C
harles Trafton
Mr. Trafton is managing partner of FlowPoint Capital
Partners
, a Boston
-
based investment manage
r
with a
short position
in Houghton Mifflin common stock.
get_app  Login to Download this PDF
More from Charles Trafton